Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PREDIRCAM eHealth platform for individualized telemedical assistance for lifestyle modification in the treatment of obesity, diabetes, and cardiometabolic risk prevention: a pilot study (PREDIRCAM 1).
González C, Herrero P, Cubero JM, Iniesta JM, Hernando ME, García-Sáez G, Serrano AJ, Martinez-Sarriegui I, Perez-Gandia C, Gómez EJ, Rubinat E, Alcantara V, Brugués E, Chico A, Mato E, Bell O, Corcoy R, de Leiva A. González C, et al. J Diabetes Sci Technol. 2013 Jul 1;7(4):888-97. doi: 10.1177/193229681300700411. J Diabetes Sci Technol. 2013. PMID: 23911170 Free PMC article. Clinical Trial.
Evaluation of a New Digital Automated Glycemic Pattern Detection Tool.
Comellas MJ, Albiñana E, Artes M, Corcoy R, Fernández-García D, García-Alemán J, García-Cuartero B, González C, Rivero MT, Casamira N, Weissmann J. Comellas MJ, et al. Among authors: gonzalez c. Diabetes Technol Ther. 2017 Nov;19(11):633-640. doi: 10.1089/dia.2017.0180. Epub 2017 Nov 1. Diabetes Technol Ther. 2017. PMID: 29091477 Free PMC article.
Web Support for Weight-Loss Interventions: PREDIRCAM2 Clinical Trial Baseline Characteristics and Preliminary Results.
Alcántara-Aragón V, Rodrigo-Cano S, Lupianez-Barbero A, Martinez MJ, Martinez C, Tapia J, Iniesta JM, Tenes S, Urgell E, Navarro G, Hernando ME, Merino-Torres JF, de Leiva A, Gonzalez C. Alcántara-Aragón V, et al. Among authors: gonzalez c. Diabetes Technol Ther. 2018 May;20(5):380-385. doi: 10.1089/dia.2017.0456. Epub 2018 Apr 5. Diabetes Technol Ther. 2018. PMID: 29620918 Clinical Trial.
Evaluation of the usefulness of and satisfaction with the flash glucose monitoring system (FreeStyle Libre®) guide for use in patients with type 1 diabetes.
Mateu-Salat M, Moreno-Fernández J, Mangas N, Genua I, Martínez MJ, López A, González C, Chico A. Mateu-Salat M, et al. Among authors: gonzalez c. Endocrinol Diabetes Nutr (Engl Ed). 2021 Aug 24:S2530-0164(21)00185-3. doi: 10.1016/j.endinu.2021.04.008. Online ahead of print. Endocrinol Diabetes Nutr (Engl Ed). 2021. PMID: 34452877 English, Spanish.
The Flash Guide (FG) for insulin dosing (A. Chico, C. Gonzalez) was the first document intended for FreeStyle Libre (FSL) user patients to help with decision-making depending on glucose level and trend. ...
The Flash Guide (FG) for insulin dosing (A. Chico, C. Gonzalez) was the first document intended for FreeStyle Libre (FSL) user …
Evaluation of the usefulness of and satisfaction with the flash glucose monitoring system (FreeStyle Libre®) guide for use in patients with type 1 diabetes⋆.
Mateu-Salat M, Moreno-Fernández J, Mangas N, Genua I, Martínez MJ, López A, González C, Chico A. Mateu-Salat M, et al. Among authors: gonzalez c. Endocrinol Diabetes Nutr (Engl Ed). 2022 May;69(5):316-321. doi: 10.1016/j.endien.2022.03.007. Epub 2022 May 14. Endocrinol Diabetes Nutr (Engl Ed). 2022. PMID: 35577748
The Flash Guide (FG) for insulin dosing (A. Chico, C. Gonzalez) was the first document intended for FreeStyle Libre (FSL) user patients to help with decision-making depending on glucose level and trend. ...
The Flash Guide (FG) for insulin dosing (A. Chico, C. Gonzalez) was the first document intended for FreeStyle Libre (FSL) user …
Effects of a Digital Patient Empowerment and Communication Tool on Metabolic Control in People With Type 2 Diabetes: The DeMpower Multicenter Ambispective Study.
Orozco-Beltrán D, Morales C, Artola-Menéndez S, Brotons C, Carrascosa S, González C, Baro Ó, Aliaga A, Ferreira de Campos K, Villarejo M, Hurtado C, Álvarez-Ortega C, Gómez-García A, Cedenilla M, Fernández G. Orozco-Beltrán D, et al. Among authors: gonzalez c. JMIR Diabetes. 2022 Oct 3;7(4):e40377. doi: 10.2196/40377. JMIR Diabetes. 2022. PMID: 36190763 Free PMC article.
5,331 results